All Categories
All New Open Closed
Insider 5 Catalyst 11 Earnings 7 Contrarian 4 Macro 9 Alpha 25 Technicals 5
Opened in the last 3 days Free pick Click a pick for full details

Open picks

Avg PnL-7.87%Avg vs S&P-7.40%(2 picks)
APAM OPEN FREE PICK Chart
Artisan Partners Asset Management Inc.
Contrarian Finance Mid cap 10/7/26 (8d ago) HOLD
Hold2-4 weeks
Entry$33.76Now$32.73PnL-3.04%
HOLD
93%
conf

Angle Goldman’s fresh Sell reset may have marked capitulation while APAM still sits in a low-double-digit manager multiple band.

APAM just absorbed a negative analyst reset, with Goldman cutting its target to $31 from $35 while keeping a Sell rating [#14, #15]. The contrarian case is that the downgrade pressure is now visible and potentially priced into the washout, while relative manager valuation context still places Artisan around 11.9x trailing earnings rather than at an obviously distressed outlier multiple [#1].
Catalyst A sentiment re-rating over the next few weeks as downgrade pressure fades and buyers reassess APAM’s valuation versus listed asset-manager peers.
HOLD AI Status: APAM shows oversold stochastics and Bollinger stretch against a strong downtrend, consistent with a washout while analyst downgrade pressure may be fading.
CC OPEN FREE PICK Chart
Chemours Company
Contrarian Industrials Mid cap 8/10/26 (2mo ago) HOLD
Hold2-4 weeks
Entry$14.80Now$12.92PnL-12.71%
HOLD
66%
conf

Angle Chemours is being valued at 7x forward earnings after a post-Q2 washout, versus a chemical-peer norm near 13x.

Chemours sold off sharply after Q2, with the stock dropping about 16.7% to $14.93 following missed revenue and earnings estimates [#21]. The reversal case is valuation-driven: at $16.61, Chemours was framed as trading around 7x next-year earnings versus a typical chemicals multiple near 13x, implying fair value near $29 [#30].
Catalyst A short-horizon re-rating can come from bargain buying after the Q2 earnings washout as investors reassess the multiple gap.
HOLD AI Status: Chemours sits oversold on stochastics and at the lower Bollinger band while weekly MACD histogram turns higher, against a still-strong downtrend below the EMA20.

Closed (Last 90 Days)

Total PnL-31.40%Avg PnL-15.70%Avg vs S&P-18.70%Win %50.00%Avg days held25.5d(2 picks)
BSX CLOSED FREE PICK Chart
Boston Scientific Corporation
Contrarian Health Care Large cap 7/6/26 (3mo ago) closed Aug 11, 2026
Held26 days
Entry$44.60Close$50.99PnL+14.33%
65%
conf

Angle A full round trip to 2022 support leaves BSX priced far below sell-side targets as buyback support absorbs the flush.

BSX has been punished like a broken compounder despite an active buyback, with the accelerated repurchase at $52.68 now far above spot and highlighting the severity of the capitulation [#2]. The reversal case is sentiment and positioning: shares have round-tripped to 2022 levels near a historic support trendline, while referenced upside to average analyst targets remains unusually wide [#4, #5].
Catalyst Second-half mean reversion as support holds and investors revisit the analyst-target gap after the forced selling phase.
AI Status: BSX closed with a +14.33% realized gain after a 26-day rebound from 2022 support, finishing just 0.45% below peak.
UWMC CLOSED FREE PICK Chart
UWM Holdings Corporation
Contrarian Finance Mid cap 7/2/26 (3mo ago) closed Aug 6, 2026
Held25 days
Entry$2.17Close$1.18PnL-45.73%
66%
conf

Angle KBW's Outperform upgrade gives UWMC a fresh risk-reward reset after rate, leverage, and dividend fears washed out the stock.

UWMC's bounce has a tweet-backed sentiment hook: Keefe Bruyette upgraded UWM to Outperform while setting a $3.75 target, materially above the $2.22 close [#1, #15]. The setup is contrarian because BTIG's cited pushback says the stock remains weak on rate, leverage, and dividend concerns, so the upgrade suggests the bearish narrative may be over-discounted as daily momentum turns [#8].
Catalyst The re-rating window is the next 1-6 weeks as investors digest KBW's upgrade against a crowded negative mortgage-lender narrative.
AI Status: UWMC closed at a 45.73% loss after the KBW upgrade bounce failed and the stock kept grinding lower in a entrenched downtrend.

Open picks

Avg PnL-7.87%Avg vs S&P-7.40%(2 picks)
Ticker Name Sector Category Status Hold Conf. Entry Current PnL Published
APAM Artisan Partners Asset Management Inc. Finance Contrarian HOLD 2-4 weeks 93% $33.76 $32.73 -3.04% 8d ago
CC Chemours Company Industrials Contrarian HOLD 2-4 weeks 66% $14.80 $12.92 -12.71% 2mo ago

Closed (Last 90 Days)

Total PnL-31.40%Avg PnL-15.70%Avg vs S&P-18.70%Win %50.00%Avg days held25.5d(2 picks)
Ticker Name Sector Category Status Held Conf. Entry Close PnL Closed
BSX Boston Scientific Corporation Health Care Contrarian Closed 26 days 65% $44.60 $50.99 +14.33% 2mo ago
UWMC UWM Holdings Corporation Finance Contrarian Closed 25 days 66% $2.17 $1.18 -45.73% 2mo ago